Treatment of exacerbations of COPD

M J Rosen1

  • 1Beth Israel Medical Center, New York, New York.

American Family Physician
|February 1, 1992
PubMed

Insights

Chronic obstructive pulmonary disease (COPD) impacts millions, with common treatments including bronchodilators and antibiotics. Bacterial infections by Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis frequently occur during COPD exacerbations.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a significant public health issue affecting approximately 14 million Americans.
  • Current management strategies for COPD involve bronchodilators, corticosteroids, and antibiotics.
  • Bacterial infections are a major cause of exacerbations in COPD patients.

Purpose of the Study:

  • To identify the most common bacterial pathogens implicated in COPD exacerbations.
  • To provide insights into the microbial landscape of COPD exacerbations.

Main Methods:

  • Retrospective analysis of clinical data from COPD patients experiencing exacerbations.
  • Identification of bacterial isolates from respiratory samples using standard microbiological techniques.

Main Results:

  • The most frequently isolated bacteria during COPD exacerbations were identified.
  • Haemophilus influenzae was a predominant isolate.
  • Streptococcus pneumoniae and Moraxella catarrhalis were also commonly identified.

Conclusions:

  • Understanding the common bacterial culprits in COPD exacerbations is crucial for effective treatment.
  • Targeted antibiotic therapy against Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis may be beneficial during COPD exacerbations.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...